Opening Plenary Session

Tuesday, October 6, 2009
9:00 am to 11:30 am
Masur Auditorium, Building 10

Opening Remarks
Francis S. Collins, Director of the National Institutes of Health

Influenza A – Pathogenesis and Pandemics
Co-Chairs: Kathryn Zoon, NIAID and Brian R. Murphy, NIAID

The Influenza A Virus shows enormous adaptability in the evasion of immunity that builds up in the human population resulting in new drift and pandemic strains. The emergence of new strains, the pathogenesis of virus in the human and animal or avian reservoir host, and the development of vaccines, including new methods to probe the antibody response to vaccines, will be addressed in the presentations and the discussions.

Program

Pathogenesis of Influenza A Virus Infections
Jeff Taubenberger, NIAID

Influenza Vaccines: The Next Generation
Gary Nabel, NIAID

Pandemic Influenza Preparedness – New Molecular Tools for Evaluation of Humoral Responses Elicited by Vaccines
Hana Golding, CBER, FDA

A New Model for Influenza A Virus Antigenic Drift
Scott Hensley, NIAID

Vaccines for Pandemic Influenza Viruses
Kanta Subbarao, NIAID